NCT07277556 (TURP-SCORE) is a clinical trial in Benign Prostatic Hyperplasia (BPH), sponsored by General Hospital Sveti Duh.

Who is sponsoring NCT07277556?

NCT07277556 is sponsored by General Hospital Sveti Duh.

What condition does NCT07277556 study?

NCT07277556 studies Benign Prostatic Hyperplasia (BPH).

Is NCT07277556 still recruiting?

NCT07277556 is currently not yet recruiting. Last updated 19 December 2025.

Last reviewed 2025-12-19 · How we verify

NCT07277556: TURP-SCORE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TURP Outcome Prediction Calculator Study

Not yet recruiting Last updated 19 December 2025

What this trial tests

trial in Benign Prostatic Hyperplasia (BPH) in 200 participants. Not yet recruiting.

Timeline

2 March 2026

Primary endpoint
1 March 2027

13 December 2027

Quick facts

Lead sponsor	General Hospital Sveti Duh
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	200
Start date	2 March 2026
Primary completion	1 March 2027
Estimated completion	13 December 2027

Conditions studied

Benign Prostatic Hyperplasia (BPH) — all drugs for Benign Prostatic Hyperplasia (BPH) →

Sponsor

General Hospital Sveti Duh

Who can join

18 and older, male only, with Benign Prostatic Hyperplasia (BPH). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to identify which preoperative clinical, ultrasound, and uroflowmetry parameters can help predict the success of transurethral resection of the prostate (TURP) in adult male patients with symptomatic benign prostatic hyperplasia (BPH). The main questions it aims to answer are: Which preoperative parameters (IPSS, prostate volume, post-void residual urine, Qmax, comorbidities) are associated with successful postoperative outcomes? Can these parameters be used to develop a non-invasive calculator to estimate the likelihood of TURP success? Participants will undergo routine clinical evaluation that is part of standard care, including: * completion of the IPSS questionnaire * digital rectal examination * ultrasound measurement of prostate volume and residual urine * uroflowmetry (Qmax and voided volume) * standard laboratory testing Eligible participants will then undergo TURP as clinically indicated and return for postoperative assessments of symptom improvement and urinary flow parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Benign Prostatic Hyperplasia (BPH)

Currently open trials in the same condition.

NCT07016620 — Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia · recruiting
NCT06817733 — Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging · NA · recruiting
NCT06062875 — Effects of TNF Blockade on Human BPH/LUTS · Phase 2 · recruiting
NCT04266418 — The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults · NA · recruiting
NCT04757116 — Post-Market Study to Assess iTind Safety in Comparison to UroLift · NA · recruiting

Other General Hospital Sveti Duh trials

Trials by the same sponsor.

NCT07285408 — Sarcopenia and NMIBC Prognosis Study · not yet recruiting
NCT04837924 — Fascia Iliaca Compartment Block for Pain Management in Hip Fracture Patients · Phase 4 · completed
NCT04607031 — Prognostic Accuracy of ST2 Dynamics in Ischemic Stroke Outcome · completed
NCT04276519 — Position-Induced Opening of the Intervertebral Foramen is Efficient to Treat an Acute Lumbosacral Radiculopathy Caused b · NA · completed
NCT03085862 — Lung Ultrasonography and Extravascular Lung Water · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07277556 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by General Hospital Sveti Duh
Last refreshed: 19 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07277556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing